Top Cited Articles
Acceptance rate:
40%
Time to first decision with review (median):
35 days*
Time to first decision without review (median):
5 days*
Acceptance to publication:
21 days*
Impact Factor (JCR):
4.1
Citescore:
6.6
Total content views:
513,584
ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023*
Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program
Global challenges of radiotherapy for the treatment of locally advanced cervical cancer
Advances in immunotherapy for cervical cancer: recent developments and future directions
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study
Updates in the treatment of vaginal cancer
European Society of Gynaecological Oncology Guidelines for the Management of Patients with Vulvar Cancer-Update 2023
Avascular spaces in radical hysterectomy
ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)
The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions
Neoadjuvant chemotherapy followed by surgery in cervical cancer: past, present and future
Magnetic resonance imaging-radiomics in endometrial cancer: a systematic review and meta-analysis
Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia
Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy
Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: a systematic review and meta-analysis